Robert J. Kurman

Active 1972–2023

Also published as
ROBERT J. KURMAN
204
Papers
54,996
Citations
137
h-index
204
i10-index

Citations

Citations per year for Robert J. Kurman1971: 1 citations1972: 1 citations1973: 1 citations1974: 5 citations1975: 6 citations1976: 5 citations1977: 14 citations1978: 12 citations1979: 7 citations1980: 10 citations1981: 8 citations1982: 20 citations1983: 11 citations1984: 11 citations1985: 16 citations1986: 11 citations1987: 22 citations1988: 16 citations1989: 23 citations1990: 28 citations1991: 35 citations1992: 29 citations1993: 21 citations1994: 58 citations1995: 77 citations1996: 98 citations1997: 104 citations1998: 120 citations1999: 141 citations2000: 254 citations2001: 222 citations2002: 256 citations2003: 312 citations2004: 366 citations2005: 390 citations2006: 347 citations2007: 422 citations2008: 382 citations2009: 392 citations2010: 429 citations2011: 448 citations2012: 525 citations2013: 446 citations2014: 337 citations2015: 383 citations2016: 373 citations2017: 308 citations2018: 290 citations2019: 1,185 citations2020: 1,143 citations2021: 830 citations2022: 687 citations2023: 441 citations2024: 632 citations2025: 232 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,903 citing papers, 30.4% of this breakdownUnited Kingdom: 879 citing papers, 6.8% of this breakdownChina: 818 citing papers, 6.4% of this breakdownCanada: 638 citing papers, 5% of this breakdownItaly: 547 citing papers, 4.3% of this breakdownJapan: 495 citing papers, 3.9% of this breakdownGermany: 447 citing papers, 3.5% of this breakdownFrance: 439 citing papers, 3.4% of this breakdownNetherlands: 404 citing papers, 3.1% of this breakdownAustralia: 375 citing papers, 2.9% of this breakdownSpain: 302 citing papers, 2.4% of this breakdownBelgium: 229 citing papers, 1.8% of this breakdown
0%30.4%Other 26.1%

Fields

  • Medicine76.4%
  • Biochemistry, Genetics and Molecular Biology16.4%
  • Immunology and Microbiology4.2%
  • Computer Science0.8%
  • Environmental Science0.3%
  • Neuroscience0.3%
  • Other1.6%

Topics

  • Ovarian cancer diagnosis and treatment10.4%
  • Cervical Cancer and HPV Research8.8%
  • Endometrial and Cervical Cancer Treatments7.7%
  • Genital Health and Disease2.2%
  • Endometriosis Research and Treatment2.2%
  • Uterine Myomas and Treatments1.7%
  • Other67%

Coauthors

All papers

Open in search
  1. High grade serous ovarian carcinomas originate in the fallopian tube

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 767

  2. The Dualistic Model of Ovarian Carcinogenesis

    Authors: , - American Journal Of Pathology 2016 cited by 922

  3. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

    Authors: , - The American Journal of Surgical Pathology 2010 cited by 1,839

  4. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

    Authors: , , , , , , , , , - Gynecologic Oncology 2008 cited by 866

  5. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 cited by 459

  6. WHO classification of tumours of female reproductive organs

    Authors: , , , - International Agency for Research on Cancer eBooks 2014 cited by 1,963

  7. Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2011 cited by 520

  8. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Karchin, Cristian Tomasetti, Kenneth W. Kinzler, Bert Vogelstein, Amanda N. Fader, Lucy Gilbert, Nickolas Papadopoulos - Science Translational Medicine 2018 cited by 243

  9. Ovarian Tumorigenesis

    Authors: , - American Journal Of Pathology 2004 cited by 1,200

  10. Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis

    Authors: , , , , , , - Modern Pathology 2011 cited by 535

  11. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

    Authors: , - Human Pathology 2011 cited by 1,073

  12. Ovarian Low-grade and High-grade Serous Carcinoma

    Authors: , , - Advances in Anatomic Pathology 2009 cited by 556

  13. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions

    Authors: , , , , , , , , , , , , , - The Journal of Pathology 2018 cited by 143

  14. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases

    Authors: , , , - International Journal of Gynecological Pathology 2016 cited by 198

  15. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2005 cited by 1,580

  16. Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population

    Authors: , , , , , , , , , , , , , , - Gynecologic Oncology 2019 cited by 94

  17. Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma

    Authors: , , , , , , , , , - The American Journal of Surgical Pathology 2011 cited by 286

  18. The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin

    Authors: , , , , , - International Journal of Gynecological Pathology 2003 cited by 562

  19. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients

    Authors: , , - Cancer 1985 cited by 1,266

  20. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma

    Authors: , , , , , , , , , - Nature Communications 2017 cited by 234

  21. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

    Authors: , , , , , , - Gynecologic Oncology 1991 cited by 1,305

  22. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high‐grade serous carcinoma—evidence supporting the clonal relationship of the two lesions

    Authors: , , , , , , , - The Journal of Pathology 2011 cited by 398

  23. Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2013 cited by 326

  24. Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety

    Authors: , , , , , , , , , , , , , , , , , , , , - PEDIATRICS 2023 cited by 46